Research on microencapsulation to develop food and drug administration (FDA) packages for premarket notification (also called PMN or 510(k) approval) for tissue imaging markers, and initiate…
Ended Cooperative Agreement Awarded Last action
- Contract number
- NNJ16GU04A
- Awardee
-
Nuvue Therapeutics Inc. UEI J4FDPRMANY17
- Awarding agency
-
Johnson Space Center
National Aeronautics and Space Administration
- Obligated
- $1,955,755
Award facts
- Contract value 100% obligated
- $1,955,755.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 0 offers Basic Research
- Pricing
- Other
- Place of performance
- Bristow, VA 20136, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $52,895 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $963,988 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $938,872 |
Show all 12
About this award
The U.S. National Aeronautics and Space Administration (NASA) Johnson Space Center awarded a $1,955,755.46 cooperative agreement to Nuvue Therapeutics Inc., a small disadvantaged business, to conduct research on microencapsulation for the development of Food and Drug Administration (FDA) packages for premarket notification (510(k) approval) of tissue imaging markers and to initiate pre-clinical trials for the encapsulation of chemotherapeutic agents. The contract has no set-aside designation and is set to be completed by May 31, 2018.
Description
Research on microencapsulation to develop food and drug administration (FDA) packages for premarket notification (also called PMN or 510(k) approval) for tissue imaging markers, and initiate pre-clinical trials for the encapsulation of chemotherapeutic agents.
Quick answers
Who was awarded contract NNJ16GU04A?
NNJ16GU04A was awarded to Nuvue Therapeutics Inc. by Johnson Space Center (National Aeronautics and Space Administration) on May 27, 2016.
How much is contract NNJ16GU04A worth?
The government has obligated $1,955,755 on NNJ16GU04A.
Was contract NNJ16GU04A competed?
The extent of competition for NNJ16GU04A was full and open competition. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award